Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112334463 | 11233446 | 3 | F | 201409 | 20160728 | 20150702 | 20160803 | EXP | GB-ABBVIE-15K-167-1419044-00 | ABBVIE | 61.05 | YR | M | Y | 76.20000 | KG | 20160803 | OT | COUNTRY NOT SPECIFIED | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112334463 | 11233446 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION | |||||||
| 112334463 | 11233446 | 2 | C | BISOPROLOL | BISOPROLOL | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 4 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 5 | C | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | ||||||||||||
| 112334463 | 11233446 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112334463 | 11233446 | 1 | Psoriasis |
| 112334463 | 11233446 | 2 | Product used for unknown indication |
| 112334463 | 11233446 | 3 | Product used for unknown indication |
| 112334463 | 11233446 | 4 | Product used for unknown indication |
| 112334463 | 11233446 | 5 | Product used for unknown indication |
| 112334463 | 11233446 | 6 | Product used for unknown indication |
| 112334463 | 11233446 | 7 | Product used for unknown indication |
| 112334463 | 11233446 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112334463 | 11233446 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112334463 | 11233446 | Abdominal lymphadenopathy | |
| 112334463 | 11233446 | Adrenal disorder | |
| 112334463 | 11233446 | Back pain | |
| 112334463 | 11233446 | Fatigue | |
| 112334463 | 11233446 | Hypertension | |
| 112334463 | 11233446 | Metastases to bone | |
| 112334463 | 11233446 | Myocardial ischaemia | |
| 112334463 | 11233446 | Pulmonary embolism | |
| 112334463 | 11233446 | Pulmonary mass | |
| 112334463 | 11233446 | Small cell lung cancer metastatic | |
| 112334463 | 11233446 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112334463 | 11233446 | 1 | 20131014 | 20140205 | 0 | |
| 112334463 | 11233446 | 2 | 20050809 | 0 | ||
| 112334463 | 11233446 | 3 | 20050801 | 0 | ||
| 112334463 | 11233446 | 4 | 20050801 | 0 | ||
| 112334463 | 11233446 | 5 | 20050801 | 0 | ||
| 112334463 | 11233446 | 6 | 20050801 | 0 | ||
| 112334463 | 11233446 | 7 | 20050801 | 0 | ||
| 112334463 | 11233446 | 8 | 20050801 | 0 |